Unknown

Dataset Information

Study on the mechanism of lupenone for treating type 2 diabetes by integrating pharmacological evaluation and network pharmacology.


ABSTRACT:

Context

Lupenone (LUP) is the active ingredient of Musa basjoo Sieb. et Zucc. (Musaceae) with antidiabetes effects, but an unclear underlying mechanism of action.

Objective

Animal experiments combined with network pharmacology were used to explore the mechanism of LUP for treating diabetes.

Materials and methods

Insulin resistance (IR) in male Sprague-Dawley rats with type 2 diabetic was induced using a high-fat diet and streptozotocin. The selected rats were divided into normal group, model group, positive group and LUP (2.0, 4.0 and 8.0 mg/kg) groups, and orally administrated twice daily with Tween 80, rosiglitazone or LUP. Fasting blood glucose (FBG), oxidative stress index, blood lipids and IR-related targets were detected. A network pharmacology analysis w

SUBMITTER: Xu F 

PROVIDER: S-EPMC9154797 | biostudies-literature | 2022 Dec

REPOSITORIES: biostudies-literature